This HTML5 document contains 116 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50864848
rdf:type
wikibase:Item
schema:description
מאמר מדעי επιστημονικό άρθρο artigo científico vitenskapelig artikkel vedecký článok 1998年學術文章 مقالة علمية نشرت في سبتمبر 1998 наукова стаття, опублікована у вересні 1998 articol științific artikull shkencor 1998年學術文章 videnskabelig artikel article scientifique artigo científico vitskapeleg artikkel 1998年学术文章 1998年学术文章 научна статия artykuł naukowy научни чланак naučni članak мақолаи илмӣ artículu científicu scientific article published in September 1998 სამეცნიერო სტატია artikel ilmiah artikulong pang-agham tudományos cikk บทความทางวิทยาศาสตร์ সেপ্টেম্বর ১৯৯৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 1998年学术文章 artículo científico publicado en 1998 1998年学术文章 научная статья articolo scientifico 1998年学术文章 scientific article published in September 1998 teaduslik artikkel vetenskaplig artikel vědecký článek 1998年學術文章 1998年學術文章 scienca artikolo scientific article published in September 1998 article científic wetenschappelijk artikel 1998年學術文章 bài báo khoa học wissenschaftlicher Artikel tieteellinen artikkeli 1998年の論文 artigo científico 1998 nî lūn-bûn bilimsel makale 1998년 논문 научни чланак 1998年学术文章 article scientific
p:P577
wds:Q50864848-A08DBB71-11CD-438E-BE7B-30E0A2C740D3
wdt:P577
1998-09-01T00:00:00Z
p:P2093
wds:Q50864848-F4F4FB59-E731-413B-8AF5-9EE6B251565A wds:Q50864848-D6004339-B972-4560-9F4A-E19366FFCAC5 wds:Q50864848-E77B8551-654D-4D71-A863-E36C9043CE44 wds:Q50864848-C98528F0-983D-470A-BC7A-2133DC058D7D wds:Q50864848-D4D35998-89DF-4615-A0EE-45577664D629 wds:Q50864848-A5C7A172-180B-4002-B20E-1FEE72CCA454 wds:Q50864848-AC34E0D0-965A-4A1C-9547-36FA2C4C7707 wds:Q50864848-9EC77E99-F92E-42DA-93D1-DB1856AA4DD4 wds:Q50864848-950A1B09-9F2D-4B15-BCAB-370941E2FF38 wds:Q50864848-6FF869AF-C95C-4E7F-A1B2-45DBECEA0563 wds:Q50864848-5E69AA1A-F05D-444D-9F14-AD2998680CB3 wds:Q50864848-2EFBB419-C5FD-43FF-ACDE-CA5876FA635D wds:Q50864848-15329405-A19E-4531-BFF9-7470C953B39D wds:Q50864848-0AF94EBA-831B-42FB-B1B7-374123CD7C55
wdt:P2093
Gammon MD Risch HA Hansten PD West AB Stanford JL Rotterdam H Schoenberg JB Fraumeni JF Jr Vaughan TL Dubrow R Mayne ST Ahsan H Chow WH Farrow DC
rdfs:label
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
skos:prefLabel
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
schema:name
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
p:P50
wds:Q50864848-354A4C14-4F53-4814-AE0B-683FF42AB5E4
wdt:P50
wd:Q91272971
p:P1476
wds:Q50864848-3C885E19-5F6C-4FC1-AF41-E4F08D7C701A
wdt:P1476
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux
p:P304
wds:Q50864848-34C634FC-0E7D-44B5-ADC1-C9B809E58664
wdt:P304
749-756
p:P31
wds:Q50864848-6F95623B-A047-4278-A579-61D05A793A90
wdt:P31
wd:Q13442814
p:P921
wds:Q50864848-99DDC083-B9C3-47DC-BFB6-D462D02F2627 wds:Q50864848-04F59A05-C8DE-4C19-AFF8-CA4FB46E271E
wdt:P921
wd:Q356033 wd:Q35869
p:P698
wds:Q50864848-72E6B114-3DBB-402B-B6F5-D8C8831D8A96
wdtn:P698
n11:9752982
wdt:P698
9752982
p:P1433
wds:Q50864848-8B82F6DB-BABF-44D6-B8A9-E88D3033CD07
wdt:P1433
wd:Q326334
p:P433
wds:Q50864848-1B2C0381-6CA7-4EAB-91FC-4AE3BBE1D427
p:P478
wds:Q50864848-789D746E-A10C-4C83-AD27-EAD866D6EA6F
wdt:P433
9
wdt:P478
7